Regulation of HHLA2 expression in kidney cancer and myeloid cells

被引:0
|
作者
Tomonari Shigemura
Nahuel Perrot
Zimo Huang
Rupal S. Bhatt
Aseman Bagheri Sheshdeh
Nourhan El Ahmar
Fatme Ghandour
Sabina Signoretti
David F. McDermott
Gordon J. Freeman
Kathleen M. Mahoney
机构
[1] Harvard Medical School,Department of Medical Oncology, Dana
[2] Beth Israel Deaconess Medical Center,Farber Cancer Institute
[3] Harvard Medical School,Department of Medicine, Division of Medical Oncology
[4] Brigham and Women’s Hospital,Department of Pathology
[5] Harvard Medical School,undefined
来源
BMC Cancer | / 23卷
关键词
HHLA2; KIR3DL3; Kidney cancer; ccRCC; Monocytes; Tumor microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Regulation of HHLA2 expression in kidney cancer and myeloid cells
    Shigemura, Tomonari
    Perrot, Nahuel
    Huang, Zimo
    Bhatt, Rupal S.
    Sheshdeh, Aseman Bagheri
    Ahmar, Nourhan El
    Ghandour, Fatme
    Signoretti, Sabina
    Mcdermott, David F.
    Freeman, Gordon J.
    Mahoney, Kathleen M.
    BMC CANCER, 2023, 23 (01)
  • [2] Regulation of HHLA2 expression in renal cell carcinoma and myeloid cells
    Shigemura, Tomonari
    Perrot, Nahuel
    Huang, Zimo
    Sheshdeh, Aseman Bagheri
    El Ahmar, Nourhan
    McDermott, David
    Signoretti, Sabina
    Freeman, Gordon
    Mahoney, Kathleen
    CANCER RESEARCH, 2023, 83 (16)
  • [3] HHLA2 immune-regulatory roles in cancer
    Mortezaee, Keywan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [4] HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
    Xu, Yituo
    Huang, Zhijie
    Yu, Xingjuan
    Li, Zhixiong
    Zheng, Limin
    Xu, Jing
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 329 - 341
  • [5] Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
    Kula, Agnieszka
    Dawidowicz, Miriam
    Mielcarska, Sylwia
    Kiczmer, Pawel
    Skiba, Hanna
    Krygier, Malgorzata
    Chrabanska, Magdalena
    Piecuch, Jerzy
    Szrot, Monika
    Robotycka, Julia
    Ochman, Blazej
    Strzalkowska, Bogumila
    Czuba, Zenon
    Swietochowska, Elzbieta
    Waniczek, Dariusz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [6] Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer
    Wang, Hongbo
    An, Zhonghua
    Liu, Yingzhou
    Ding, Guanghui
    Deng, Guojin
    Ji, Changsheng
    Gong, Yanling
    CURRENT CANCER DRUG TARGETS, 2024, 24 (11) : 1177 - 1186
  • [7] HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors
    de Gonzalez, Anne K. Koehne
    Yan, Han
    Su, Gloria H.
    Remotti, Helen
    LABORATORY INVESTIGATION, 2018, 98 : 681 - 681
  • [8] EXPRESSION OF HHLA2 IN CARDIA CARCINOMA AND ITS CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS
    Zheng, Xiaodong
    Zhang, Weimin
    Yue, Guangchen
    Wei, Xudong
    Nie, Shiwei
    ACTA MEDICA MEDITERRANEA, 2022, 38 (05): : 3251 - 3255
  • [9] High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma
    Niu, Yongzhi
    Wang, Wei
    Jiang, Xiaodan
    Huang, Yichuan
    Yan, Shu
    Jiang, Yan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (07) : 751 - 757
  • [10] HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors
    de Gonzalez, Anne K. Koehne
    Yan, Han
    Su, Gloria H.
    Remotti, Helen
    MODERN PATHOLOGY, 2018, 31 : 681 - 681